Recent studies uncovered that BCL11A was a critical oncogene in many other cancers like triple-negative breast cancer, lung squamous carcinoma, colorectal cancer, and laryngeal squamous cell carcinoma (36–39). This evidence concerns the gene BCL11A and triple-negative breast carcinoma.